Gilles Favre

7PUBLICATIONS
43CO-AUTHORS
Molecular targetsMedical infection agents (incl. prions)Liquid biopsiesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 23, 2026
Persistent TOP1 cleavage complexes in drug-tolerant cells drive adaptive resistance to EGFR-targeted therapies in lung cancer.

|Jun 27, 2024
Farnesyltransferase inhibition overcomes oncogene-addicted non-small cell lung cancer adaptive resistance to targeted therapies.

Sarah Figarol, Célia Delahaye, Rémi Gence

|Mar 29, 2023
Productive HIV-1 infection of tissue macrophages by fusion with infected CD4+ T cells.

Rémi Mascarau, Marie Woottum, Léa Fromont

|Nov 19, 2020
Liquid Biopsy of Non-Plasma Body Fluids in Non-Small Cell Lung Cancer: Look Closer to the Tumor!

Lucile Durin, Anne Pradines, Céline Basset

|Dec 02, 2017
High-content tripartite split-GFP cell-based assays to screen for modulators of small GTPase activation.

Faten Koraïchi, Rémi Gence, Catherine Bouchenot

|Dec 23, 2016
The RAS-related GTPase RHOB confers resistance to EGFR-tyrosine kinase inhibitors in non-small-cell lung cancer via an AKT-dependent mechanism.

Olivier Calvayrac, Julien Mazières, Sarah Figarol

Pageof 2

Frequent Collaborators

3 joint publications

Julien Mazières

2 joint publications

Nicolas Bery

2 joint publications

Laura Keller

2 joint publications

Olivier Calvayrac